Sep 07

Print this Post

Ancure (Bettinger Group spin-out) receives SBIR grant from NIH

Ancure is a Bettinger Group spin-out that is translating new materials for applications in treating intracranial aneurysms. Ancure recently received a SBIR Phase II grant to fund in vivo experiments with partners at the Mayo Clinic in Rochester, MN.


Permanent link to this article: http://biomicrosystems.net/2020/09/ancure-bettinger-group-spin-out-receives-sbir-grant-from-nih/